Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

NCT04134000 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Invasive Bladder Cancer

Interventions

DRUG: Atezolizumab
DRUG: BCG

Sponsor

Fundacion Oncosur

Collaborators

[object Object]